greeksoup/ stock research

Dolby Laboratories (DLB) FY2024 results: revenue $1.3 billion, down 2.0% on the year

Dolby Laboratories, Inc. (DLB) reported revenue of $1.3 billion for fiscal 2024, the year ended 27 September 2024, down 2.0% on the year before. Net income was $262 million, up 30.5%, and diluted earnings per share $2.69. The figures are the company's own, from the 10-K it filed with the SEC on 19 November 2024.

Revenue
$1.3 billion
-2.0% on the year
FY2017FY2024
Operating margin
20.3%
16.6% a year earlier
FY2017FY2024
Net income
$262 million
+30.5% on the year
FY2017FY2024
Diluted EPS
$2.69
+31.2% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue1,2741,3001,254-2.0%
Cost of revenue140153141-7.9%
Gross profit1,1331,1471,112-1.2%
Gross margin89.0%88.3%88.7%
Research and development264272261-2.9%
Operating income258216207+19.7%
Operating margin20.3%16.6%16.5%
Interest expensen/an/a0.4
Pre-tax income312250215+25.0%
Income tax48.248.431.4-0.5%
Effective tax rate15.4%19.4%14.6%
Net income262201184+30.5%
Net margin20.6%15.4%14.7%
Diluted EPS$2.69$2.05$1.81+31.2%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow327367319-10.9%
Capital expenditure30.030.347.9-1.1%
Free cash flow297337271-11.7%
Free cash flow margin23.3%25.9%21.6%
Cash from investing-28654.2-296
Cash from financing-288-237-611
Depreciation and amortisation75.682.688.5-8.5%
Share-based compensation120118115+1.1%
Buybacks160149530+7.2%
Dividends paid115103100+10.8%
Dividend per share$1.23$1.11$1.02+10.8%
Diluted shares, weighted97m98m102m-0.4%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity2,4772,3552,246+5.2%
Non-controlling interest9.717.14.8-43.0%
Debt0.00.00.0
Operating lease liabilities34.837.037.7-6.1%
Other liabilities588571401+3.1%
Total liabilities and equity3,1102,9802,690+4.4%
Fixed assets479482513-0.5%
Goodwill533408365+30.6%
Intangible assets435167112+159.5%
Investments89.3237292-62.3%
Cash and equivalents482745620-35.3%
Receivables315262244+20.3%
Inventory33.735.623.5-5.3%
Other assets743642520+15.6%
Total assets3,1102,9802,690+4.4%

10-K for the year ended 27 September 2024, filed 19 November 2024: the filing.